469 related articles for article (PubMed ID: 10644013)
21. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
[TBL] [Abstract][Full Text] [Related]
22. alpha-MSH and the regulation of melanocyte function.
Thody AJ
Ann N Y Acad Sci; 1999 Oct; 885():217-29. PubMed ID: 10816655
[TBL] [Abstract][Full Text] [Related]
23. Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro.
Eberle J; Garbe C; Wang N; Orfanos CE
Pigment Cell Res; 1995 Dec; 8(6):307-13. PubMed ID: 8789739
[TBL] [Abstract][Full Text] [Related]
24. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma.
Busam KJ; Iversen K; Coplan KC; Jungbluth AA
Am J Surg Pathol; 2001 Feb; 25(2):197-204. PubMed ID: 11176068
[TBL] [Abstract][Full Text] [Related]
25. Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis.
Suzuki I; Cone RD; Im S; Nordlund J; Abdel-Malek ZA
Endocrinology; 1996 May; 137(5):1627-33. PubMed ID: 8612494
[TBL] [Abstract][Full Text] [Related]
26. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
[TBL] [Abstract][Full Text] [Related]
27. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes.
Martínez-Esparza M; Solano F; García-Borrón JC
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):991-1000. PubMed ID: 10644003
[TBL] [Abstract][Full Text] [Related]
28. Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene.
Chluba-de Tapia J; Bagutti C; Cotti R; Eberle AN
J Cell Sci; 1996 Aug; 109 ( Pt 8)():2023-30. PubMed ID: 8856498
[TBL] [Abstract][Full Text] [Related]
29. MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma.
Lunec J; Pieron C; Thody AJ
Melanoma Res; 1992 May; 2(1):5-12. PubMed ID: 1322755
[TBL] [Abstract][Full Text] [Related]
30. The effect of thioredoxin on the expression of proopiomelanocortin-derived peptides, the melanocortin 1 receptor and cell survival of normal human keratinocytes.
Funasaka Y; Chakraborty AK; Yodoi J; Ichihashi M
J Investig Dermatol Symp Proc; 2001 Nov; 6(1):32-7. PubMed ID: 11764282
[TBL] [Abstract][Full Text] [Related]
31. The chemoresistance gene ABCG2 (MXR/BCRP1/ABCP1) is not expressed in melanomas but in single neuroendocrine carcinomas of the skin.
Deichmann M; Thome M; Egner U; Hartschuh W; Kurzen H
J Cutan Pathol; 2005 Aug; 32(7):467-73. PubMed ID: 16008690
[TBL] [Abstract][Full Text] [Related]
32. Ultraviolet B and melanocyte-stimulating hormone (MSH) stimulate mRNA production for alpha MSH receptors and proopiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes.
Chakraborty A; Slominski A; Ermak G; Hwang J; Pawelek J
J Invest Dermatol; 1995 Nov; 105(5):655-9. PubMed ID: 7594638
[TBL] [Abstract][Full Text] [Related]
33. Regulation of pigmentation in human epidermal melanocytes by functional high-affinity beta-melanocyte-stimulating hormone/melanocortin-4 receptor signaling.
Spencer JD; Schallreuter KU
Endocrinology; 2009 Mar; 150(3):1250-8. PubMed ID: 18974267
[TBL] [Abstract][Full Text] [Related]
34. Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone.
Hartmeyer M; Scholzen T; Becher E; Bhardwaj RS; Schwarz T; Luger TA
J Immunol; 1997 Aug; 159(4):1930-7. PubMed ID: 9257858
[TBL] [Abstract][Full Text] [Related]
35. Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin.
Ermak G; Slominski A
J Invest Dermatol; 1997 Feb; 108(2):160-5. PubMed ID: 9008228
[TBL] [Abstract][Full Text] [Related]
36. Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma.
Demunter A; De Wolf-Peeters C; Degreef H; Stas M; van den Oord JJ
Virchows Arch; 2001 May; 438(5):485-91. PubMed ID: 11407477
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes.
Eberle J; Weitmann S; Thieck O; Pech H; Paul M; Orfanos CE
J Invest Dermatol; 1999 Jun; 112(6):925-32. PubMed ID: 10383740
[TBL] [Abstract][Full Text] [Related]
38. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.
Eisen T; Easty DJ; Bennett DC; Goding CR
Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537
[TBL] [Abstract][Full Text] [Related]
39. The role of oncogenes and growth factors in progressive melanoma-genesis.
Albino AP
Pigment Cell Res; 1992; Suppl 2():199-218. PubMed ID: 1409423
[No Abstract] [Full Text] [Related]
40. Regulation of mammalian melanogenesis by tyrosinase inhibition.
Kameyama K; Jiménez M; Muller J; Ishida Y; Hearing VJ
Differentiation; 1989 Oct; 42(1):28-36. PubMed ID: 2515983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
